These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 34349501)
1. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model. Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501 [TBL] [Abstract][Full Text] [Related]
2. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice. Wu X; Huang R; Ai G; Chen H; Ma X; Zhang J; Huang Q; Lao J; Zeng H; Li C; Xie J; Li Y; Su Z; Chen J; Huang X J Ethnopharmacol; 2024 Dec; 335():118606. PubMed ID: 39038504 [TBL] [Abstract][Full Text] [Related]
3. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis. Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377 [TBL] [Abstract][Full Text] [Related]
4. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754 [TBL] [Abstract][Full Text] [Related]
5. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice. Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372 [TBL] [Abstract][Full Text] [Related]
6. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice. Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785 [TBL] [Abstract][Full Text] [Related]
7. Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells. Zheng J; Gong S; Wu G; Zheng X; Li J; Nie J; Liu Y; Chen B; Liu Y; Su Z; Chen J; Li Y Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2405-2416. PubMed ID: 37193772 [TBL] [Abstract][Full Text] [Related]
8. Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy. Gong S; Chen J; Zheng X; Lu X; Chen M; Li J; Su Z; Liu Y; Chen J; Xie J; Xie Q; Li Y Int Immunopharmacol; 2024 Sep; 138():112632. PubMed ID: 38986300 [TBL] [Abstract][Full Text] [Related]
9. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. Jiao L; Wang R; Dong Y; Su J; Yu J; Yan M; Chen S; Lv G J Ethnopharmacol; 2024 Oct; 333():118488. PubMed ID: 38925319 [TBL] [Abstract][Full Text] [Related]
10. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice. Zhong L; Lin Y; Gong S; Wu X; Liu Y; Chen J; Li Y; Yan F; Su Z; Xie Q Phytomedicine; 2023 Jan; 108():154521. PubMed ID: 36334387 [TBL] [Abstract][Full Text] [Related]
11. Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota. Shan B; Wu M; Chen T; Tang W; Li P; Chen J Am J Chin Med; 2022; 50(8):2199-2221. PubMed ID: 36266751 [TBL] [Abstract][Full Text] [Related]
12. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
13. Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice. Xu L; Cheng J; Lu J; Lin G; Yu Q; Li Y; Chen J; Xie J; Su Z; Zhou Q Front Pharmacol; 2022; 13():964593. PubMed ID: 36438835 [TBL] [Abstract][Full Text] [Related]
14. Berberine alleviated contrast-induced acute kidney injury by mitophagy-mediated NLRP3 inflammasome inactivation in a mice model. Yang Y; Jiang S; Mu Y; Liu C; Han Y; Jiang J; Wang Y Toxicol Appl Pharmacol; 2024 May; 486():116952. PubMed ID: 38705399 [TBL] [Abstract][Full Text] [Related]
15. Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice. Fu Q; Zhang JJ; Zhu QF; Yu LL; Wang F; Li J; He X; Ao JL; Xu GB; Wei MC; Liao XJ; Liao SG Biochem Biophys Res Commun; 2024 Jul; 716():150038. PubMed ID: 38704891 [TBL] [Abstract][Full Text] [Related]
16. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice. Wang R; Ma CH; Zhou F; Kong LD Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200 [TBL] [Abstract][Full Text] [Related]
17. Chen J; Xu L; Jiang L; Wu Y; Wei L; Wu X; Xiao S; Liu Y; Gao C; Cai J; Su Z Food Funct; 2021 Oct; 12(19):9416-9431. PubMed ID: 34606558 [No Abstract] [Full Text] [Related]
18. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040 [TBL] [Abstract][Full Text] [Related]
19. Simiao pills alleviates renal injury associated with hyperuricemia: A multi-omics analysis. Zeng L; Deng Y; Zhou X; Ji S; Peng B; Lu H; He Q; Bi J; Kwan HY; Zhou L; You Y; Wang M; Zhao X J Ethnopharmacol; 2024 Oct; 333():118492. PubMed ID: 38936642 [TBL] [Abstract][Full Text] [Related]
20. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models. Li X; Yan Z; Tian J; Zhang X; Han H; Ye F Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]